...
首页> 外文期刊>BMC Medical Informatics and Decision Making >Concordance between decision analysis and matching systematic review of randomized controlled trials in assessment of treatment comparisons: a systematic review
【24h】

Concordance between decision analysis and matching systematic review of randomized controlled trials in assessment of treatment comparisons: a systematic review

机译:决策分析与匹配在治疗比较评估中随机对照试验的系统审查之间的一致性:系统审查

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background Systematic review (SR) of randomized controlled trials (RCT) is the gold standard for informing treatment choice. Decision analyses (DA) also play an important role in informing health care decisions. It is unknown how often the results of DA and matching SR of RCTs are in concordance. We assessed whether the results of DA are in concordance with SR of RCTs matched on patient population, intervention, control, and outcomes. Methods We searched PubMed up to 2008 for DAs comparing at least two interventions followed by matching SRs of RCTs. Data were extracted on patient population, intervention, control, and outcomes from DAs and matching SRs of RCTs. Data extraction from DAs was done by one reviewer and from SR of RCTs by two independent reviewers. Results We identified 28 DAs representing 37 comparisons for which we found matching SR of RCTs. Results of the DAs and SRs of RCTs were in concordance in 73% (27/37) of cases. The sensitivity analyses conducted in either DA or SR of RCTs did not impact the concordance. Use of single (4/37) versus multiple data source (33/37) in design of DA model was statistically significantly associated with concordance between DA and SR of RCTs. Conclusions Our findings illustrate the high concordance of current DA models compared with SR of RCTs. It is shown previously that there is 50% concordance between DA and matching single RCT. Our study showing the concordance of 73% between DA and matching SR of RCTs underlines the importance of totality of evidence (i.e. SR of RCTs) in the design of DA models and in general medical decision-making.
机译:背景技术随机对照试验(RCT)的系统评价(RCT)是通知治疗选择的黄金标准。决策分析(DA)也在了解医疗保健决策方面发挥着重要作用。尚不赘述RCT的DA和匹配SR的频率是一致的。我们评估了DA的结果是否协调在患者人口,干预,控制和结果匹配的RCT中。方法我们在2008年搜索Pubmed,对于DAS比较至少两个干预措施,然后匹配RCT的SRS。从DAS的患者群体,干预,控制和结果提取数据并匹配RCT的SRS。 DAS的数据提取由一个审阅者和两个独立审稿人从RCT的SR完成。结果我们确定了28个代表37比较的DAS,我们发现RCT的SR匹配。 RCT的DAS和SRS的结果在73%(27/37)的情况下协调一致。在RCT的DA或SR中进行的敏感性分析没有影响一致性。使用单一(4/37)与DA模型设计中的多个数据源(33/37)在统计上显着与RCT的DA和SR之间的一致性相关。结论我们的研究结果说明了与RCT的SR相比的当前DA模型的高一致性。它以前所示,DA和匹配的单个RCT之间有50%的一致性。我们的研究表明,在DA和RCT的匹配之间显示了73%的一致性强调了DA模型设计中证据(即RCTS的SR)的重要性和一般医学决策。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号